Clinical Report: Temporal Patterns of Circadian Rhythms in the Tumor Microenvironment

Overview

This review highlights the role of circadian rhythms in the tumor microenvironment (TME) and their impact on immune modulation and therapeutic responses. It discusses how biological timing may influence antitumor immunity.

Background

Understanding the temporal organization of the TME is crucial as it influences tumor initiation, progression, and response to therapies. Circadian rhythms, driven by molecular feedback loops, play a significant role in regulating immune functions within the TME.

Data Highlights

No specific numerical data or trial results were provided in the source material.

Key Findings

• Circadian rhythms are essential for coordinating systemic physiology and local cellular programs in the TME.
• Immune functions such as dendritic cell migration and CD8+ T cell infiltration exhibit time-dependent features.
• Emerging therapies include small-molecule clock modulators and chronologically optimized CAR-T cell therapy.
• Future research may focus on microbiome-informed chronotherapy and multi-omics profiling.

Clinical Implications

Clinicians should consider the potential impact of circadian rhythms on immune responses when planning treatment schedules.

Conclusion

Continued research is necessary to validate these findings in clinical settings.

Related Resources & Content

1. ASCO Post, 2026 -- Does the Timing of Immunotherapy Administration Affect Outcomes in Advanced Cancers?
2. JAMA Network Open, 2026 -- Time-of-Day Immunotherapy Administration and Outcomes in Advanced Cancers: A Systematic Review and Meta-Analysis
3. The ASCO Post, 2021 -- Impact of Time of Day of Immune Checkpoint Inhibitor Infusion on Overall Survival in Patients With Metastatic Melanoma
4. Frontiers in Immunology, 2026 -- Impact of time-of-day on immune checkpoint inhibitor therapy in cancer patients: an up-to-date clinical review
5. Guidelines - ASCO -- ASCO Guidelines
6. ScienceDirect, 2024 -- Circadian tumor infiltration and function of CD8+ T cells dictate immunotherapy efficacy
7. ASCO Guidelines
8. Circadian tumor infiltration and function of CD8+ T cells dictate immunotherapy efficacy
9. Time-of-Day Immunotherapy Administration and Outcomes in Advanced Cancers: A Systematic Review and Meta-Analysis | Oncology | JAMA Network Open | JAMA Network